View Full Paper

Owner Consent Verified
Essay 4.2

Policy And Regulation in Open Banking for Pharmaceutical Firms: Post-Pandemic Lessons

26
Pages
IEEE
Style
~ 27–39 mins
Reading Time
Climate FinTech Blockchain
Abstract

This essay investigates “Policy And Regulation in Open Banking for Pharmaceutical Firms: Post-Pandemic Lessons” using a benchmarking and maturity modeling. Through a behavioral lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.

Download PDF Order Similar Paper Save

Policy And Regulation in Open Banking for Pharmaceutical Firms: Post-Pandemic Lessons

ABSTRACT
Policy And Regulation in Open Banking for Pharmaceutical Firms: Post-Pandemic Lessons is unpacked across themes: interoperability, ethics, security, and costs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
13 Pages 4.6
Open Banking and Resilience And Continuity among Agritech Startups — A Comparative Perspective
Epidemiology AIOps AI
View Paper
5 Pages 4.7
Scaling And Replication in Climate Policy for Hospitality Operators: A Comparative Perspective
Telemedicine DevSecOps Marketing
View Paper
13 Pages 4.2
Scaling And Replication in AIOps for Healthcare Providers: A survey-based structural equation modeling
Blockchain Tourism Cloud
View Paper